Reduced Tolerogenic Program Death-Ligand 1-Expressing Conventional Type 1 Dendritic Cells Are Associated with Rapid Decline in Chronic Obstructive Pulmonary Disease

Kuan-Yuan Chen,Wei-Lun Sun,Sheng-Ming Wu,Po-Hao Feng,Chiou-Feng Lin,Tzu-Tao Chen,Yueh-Hsun Lu,Shu-Chuan Ho,Yueh-Hsi Chen,Kang-Yun Lee
DOI: https://doi.org/10.3390/cells13100878
IF: 6
2024-05-21
Cells
Abstract:Background: Chronic obstructive pulmonary disease (COPD) is characterized, at least in part, by autoimmunity through amplified T helper 1 and 17 (Th1 and Th17) immune responses. The loss of immune tolerance controlled by programmed death-ligand 1 (PD-L1) may contribute to this. Objectives: We studied the tolerogenic role of PD-L1+ dendritic cells (DCs) and their subtypes in relation to specific T cell immunity and the clinical phenotypes of COPD. Methods: We used flow cytometry to analyze PD-L1 expression by the DCs and their subtypes in the peripheral blood mononuclear cells (PBMCs) from normal participants and those with COPD. T cell proliferation and the signature cytokines of T cell subtypes stimulated with elastin as autoantigens were measured using flow cytometry and enzyme-linked immunosorbent assays (ELISA), respectively. Measurement and main results: A total of 83 participants were enrolled (normal, n = 29; COPD, n = 54). A reduced PD-L1+ conventional dendritic cell 1 (cDC1) ratio in the PBMCs of the patients with COPD was shown (13.7 ± 13.7%, p = 0.03). The decrease in the PD-L1+ cDC1 ratio was associated with a rapid decline in COPD (p = 0.02) and correlated with the CD4+ T cells (r = −0.33, p = 0.02). This is supported by the NCBI GEO database accession number GSE56766, the researchers of which found that the gene expressions of PD-L1 and CD4, but not CD8 were negatively correlated from PBMC in COPD patients (r = −0.43, p = 0.002). Functionally, the PD-L1 blockade enhanced CD4+ T cell proliferation stimulated by CD3/elastin (31.2 ± 22.3%, p = 0.04) and interleukin (IL)-17A production stimulated by both CD3 (156.3 ± 54.7, p = 0.03) and CD3/elastin (148 ± 64.9, p = 0.03) from the normal PBMCs. The PD-L1 blockade failed to increase IL-17A production in the cDC1-depleted PBMCs. By contrast, there was no significant change in interferon (IFN)-γ, IL-4, or IL-10 after the PD-L1 blockade. Again, these findings were supported by the NCBI GEO database accession number GSE56766, the researchers of which found that only the expression of RORC, a master transcription factor driving the Th17 cells, was significantly negatively correlated to PD-L1 (r = −0.33, p = 0.02). Conclusions: Circulating PD-L1+ cDC1 was reduced in the patients with COPD, and the tolerogenic role was suppressed with susceptibility to self-antigens and linked to rapid decline caused by Th17-skewed chronic inflammation.
cell biology
What problem does this paper attempt to address?
### Problems Addressed by the Paper This paper aims to explore the relationship between the reduction of conventional dendritic cells type 1 (cDC1) expressing programmed death-ligand 1 (PD-L1) in patients with chronic obstructive pulmonary disease (COPD) and the rapid progression of the disease. #### Research Background - Chronic obstructive pulmonary disease (COPD) is a partially autoimmune-mediated disease characterized by enhanced T helper cell 1 (Th1) and T helper cell 17 (Th17) immune responses. - PD-L1 may influence this autoimmune phenomenon by controlling immune tolerance. #### Research Objectives - To study the tolerogenic role of PD-L1+ dendritic cells and their subtypes in specific T cell immune responses and clinical phenotypes of COPD. - To investigate the association between the reduction of PD-L1+cDC1 and the rapid progression of COPD. #### Key Findings - The proportion of PD-L1+cDC1 in peripheral blood mononuclear cells (PBMCs) of COPD patients is significantly reduced. - This reduction is associated with the rapid progression of COPD and is negatively correlated with the number of CD4+ T cells. - PD-L1 blockade enhances the proliferation of CD4+ T cells and the production of interleukin 17A (IL-17A) in response to CD3/elastin peptides in normal PBMCs. - The reduction of PD-L1+cDC1 leads to decreased tolerance to self-antigens, thereby triggering Th17-skewed chronic inflammation. In summary, this paper primarily investigates the reduction of PD-L1+cDC1 in COPD patients and its relationship with the rapid progression of the disease, as well as the underlying mechanisms.